Results
|
|
1.
|
|
|
|
2.
|
|
|
|
3.
|
|
|
|
4.
|
|
|
|
5.
|
|
|
|
6.
|
|
|
|
7.
|
|
|
|
8.
|
|
|
|
9.
|
|
|
|
10.
|
|
|
|
11.
|
|
|
|
12.
|
|
|
|
13.
|
Real-world effectiveness and safety of ombitasvir/paritaprevir/ritonavir ± dasabuvir ± ribavirin in hepatitis C: AMBER study. [electronic resource] by
- Flisiak, R
- Janczewska, E
- Wawrzynowicz-Syczewska, M
- Jaroszewicz, J
- Zarębska-Michaluk, D
- Nazzal, K
- Bolewska, B
- Bialkowska, J
- Berak, H
- Fleischer-Stępniewska, K
- Tomasiewicz, K
- Karwowska, K
- Rostkowska, K
- Piekarska, A
- Tronina, O
- Madej, G
- Garlicki, A
- Lucejko, M
- Pisula, A
- Karpińska, E
- Kryczka, W
- Wiercińska-Drapało, A
- Mozer-Lisewska, I
- Jabłkowski, M
- Horban, A
- Knysz, B
- Tudrujek, M
- Halota, W
- Simon, K
Producer: 20170829
In:
Alimentary pharmacology & therapeutics vol. 44
Availability: No items available.
|